Systemic Lupus Erythematosus Practice Test

The correct choice identifies an established association between systemic lupus erythematosus (SLE) and cardiovascular disease risk. Individuals with SLE face heightened risk factors for cardiovascular issues due to a combination of inflammation, autoimmunity, and the potential effects of corticosteroid treatments that are commonly used to manage the condition. The chronic inflammation inherent in SLE contributes to accelerated atherosclerosis, increasing the likelihood of heart attacks and strokes.

This heightened risk is particularly concerning because cardiovascular disease is one of the leading causes of morbidity and mortality in patients with SLE. Monitoring and managing cardiovascular health is crucial for individuals with SLE, making awareness of these risks an important aspect of patient care.